Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Redhill Biophrma ADR (RDHL)

Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Redhill Biophrma ADR 21 Ha'arba'a Street Tel Aviv L3 64739 ISR

www.redhillbio.com Employees: 53 P: 972-3541-3131 F: 972-354-1314

Description:

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.

Key Statistics

Overview:

Market Capitalization, $K 8,682
Enterprise Value, $K 2,322
Shares Outstanding, K 1,281
Annual Sales, $ 6,530 K
Annual Net Income, $ 23,920 K
Last Quarter Sales, $ 1,800 K
Last Quarter Net Income, $ 101,240 K
EBIT, $ 8,630 K
EBITDA, $ 14,620 K
60-Month Beta 3.68
% of Insider Shareholders 6.81%
% of Institutional Shareholders 7.20%
Float, K 1,193
% Float 93.19%
Short Volume Ratio 0.44

Growth:

1-Year Return -12.80%
3-Year Return -99.77%
5-Year Return -99.90%
5-Year Revenue Growth -21.89%
5-Year Earnings Growth 105.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/03/24
Earnings Per Share ttm 486.75
EPS Growth vs. Prev Qtr -99.03%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/20/24

RDHL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 366.31%
Debt/Equity 0.00
Price/Sales 1.32
Price/Cash Flow 0.01
Price/Book 131.28
Book Value/Share 0.05
Interest Coverage 3.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar